ImQuest BioSciences, Inc. provides services ranging from anti-infective drug and vaccine discovery and complete preclinical therapeutic development to basic initiatives in microbiology research. The firm's technical and professional expertise includes microbiology (virology, bacteriology, mycology), molecular biology, cell biology, immunology, flow cytometry and tissue culture. The multidisciplinary approach to infectious disease and cancer research allows for the rapid development of technologically current and novel programs that are required to solve the research problems of the clients drug development program.
Most recently, ImQuest has established capabilities to support the preformulation and formulation of therapeutic and prevention products.
